LGX818 (Cas No. 1269440-17-6)
Product Quick Detail
- Cas No.
- 1269440-17-6
- Formula
- C22H27ClFN7O4S
- M.Wt
- 540.01
- Purity
- 98%
- Solubility
- Solubility
- Packaging
- Fluorinated Bottles
- Delivery
- 7 Days
Specifications
LGX818 is an orally available mutated BRaf V600E inhibitor(IC50=0.3 nM) with potential antineoplastic activity.
- Country: China (Mainland)
- Market: European Union,Americas
- Founded Year: 2009
- Address: 武汉东湖高新区长城科技园光谷精工D栋402室
- Contact: Rosie Liu
